| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, Interim CFO | President | Director
2 companies
Gallagher Cam is a President, Interim CFO at IRD with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 40 sells.
Estimated insider holdings value: $12.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 2, 2021 | ZNTL Zentalis Pharmaceuticals, Inc. | Director | Sell | 10,000 | $49.58 | $495,826.53 | -0.7% | +33.9% | -41.7% | |
| Jun 1, 2021 | ZNTL Zentalis Pharmaceuticals, Inc. | Director | Sell | 10,000 | $54.06 | $540,551.32 | -1.0% | +22.1% | -55.8% | |
| May 3, 2021 | ZNTL Zentalis Pharmaceuticals, Inc. | Director | Sell | 10,000 | $59.25 | $592,504.24 | -0.5% | -16.5% | -55.8% | |
| Apr 6, 2021 | ZNTL Zentalis Pharmaceuticals, Inc. | Director | Sell | 28,369 | $43.40 | $1,231,238.44 | -1.0% | +8.8% | +13.6% | |
| Mar 1, 2021 | ZNTL Zentalis Pharmaceuticals, Inc. | Director | Sell | 10,000 | $41.69 | $416,858.00 | -1.7% | - | - | |
| Feb 1, 2021 | ZNTL Zentalis Pharmaceuticals, Inc. | Director | Sell | 10,000 | $37.49 | $374,865.43 | -0.9% | - | - | |
| Jan 4, 2021 | ZNTL Zentalis Pharmaceuticals, Inc. | Director | Sell | 10,000 | $51.93 | $519,323.14 | -0.4% | - | - | |
| Dec 24, 2020 | ZNTL Zentalis Pharmaceuticals, Inc. | Director | Sell | 18,473 | $0.00 | - | -40.4% | - | - | |
| Dec 8, 2020 | ZNTL Zentalis Pharmaceuticals, Inc. | Director | Sell | 36,739 | $54.99 | $2,020,268.78 | -0.6% | - | - | |
| Dec 2, 2020 | ZNTL Zentalis Pharmaceuticals, Inc. | Director | Sell | 10,000 | $51.43 | $514,334.16 | -0.4% | - | - |